Concentrix Statistics
Total Valuation
Concentrix has a market cap or net worth of $1.97 billion. The enterprise value is $7.22 billion.
| Market Cap | 1.97B |
| Enterprise Value | 7.22B |
Important Dates
The next estimated earnings date is Thursday, September 24, 2026, after market close.
| Earnings Date | Sep 24, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
Concentrix has 61.02 million shares outstanding. The number of shares has decreased by -3.83% in one year.
| Current Share Class | 61.02M |
| Shares Outstanding | 61.02M |
| Shares Change (YoY) | -3.83% |
| Shares Change (QoQ) | -0.71% |
| Owned by Insiders (%) | 3.03% |
| Owned by Institutions (%) | 108.05% |
| Float | 47.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.77 |
| PS Ratio | 0.20 |
| Forward PS | 0.20 |
| PB Ratio | 0.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.84 |
| P/OCF Ratio | 2.65 |
| PEG Ratio | 0.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.66, with an EV/FCF ratio of 14.06.
| EV / Earnings | n/a |
| EV / Sales | 0.72 |
| EV / EBITDA | 5.66 |
| EV / EBIT | 11.63 |
| EV / FCF | 14.06 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 2.04.
| Current Ratio | 1.18 |
| Quick Ratio | 0.87 |
| Debt / Equity | 2.04 |
| Debt / EBITDA | 3.17 |
| Debt / FCF | 10.72 |
| Interest Coverage | 2.22 |
Financial Efficiency
Return on equity (ROE) is -37.66% and return on invested capital (ROIC) is 7.66%.
| Return on Equity (ROE) | -37.66% |
| Return on Assets (ROA) | 3.39% |
| Return on Invested Capital (ROIC) | 7.66% |
| Return on Capital Employed (ROCE) | 7.82% |
| Weighted Average Cost of Capital (WACC) | 4.69% |
| Revenue Per Employee | $21,976 |
| Profits Per Employee | -$2,894 |
| Employee Count | 455,000 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Concentrix has paid $77.88 million in taxes.
| Income Tax | 77.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.82% in the last 52 weeks. The beta is 0.43, so Concentrix's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -38.82% |
| 50-Day Moving Average | 24.91 |
| 200-Day Moving Average | 30.67 |
| Relative Strength Index (RSI) | 75.49 |
| Average Volume (20 Days) | 1,169,788 |
Short Selling Information
The latest short interest is 10.57 million, so 17.33% of the outstanding shares have been sold short.
| Short Interest | 10.57M |
| Short Previous Month | 10.31M |
| Short % of Shares Out | 17.33% |
| Short % of Float | 22.43% |
| Short Ratio (days to cover) | 8.99 |
Income Statement
In the last 12 months, Concentrix had revenue of $10.00 billion and -$1.32 billion in losses. Loss per share was -$21.35.
| Revenue | 10.00B |
| Gross Profit | 3.45B |
| Operating Income | 620.74M |
| Pretax Income | -1.24B |
| Net Income | -1.32B |
| EBITDA | 1.27B |
| EBIT | 620.74M |
| Loss Per Share | -$21.35 |
Balance Sheet
The company has $255.57 million in cash and $5.50 billion in debt, with a net cash position of -$5.25 billion or -$86.02 per share.
| Cash & Cash Equivalents | 255.57M |
| Total Debt | 5.50B |
| Net Cash | -5.25B |
| Net Cash Per Share | -$86.02 |
| Equity (Book Value) | 2.70B |
| Book Value Per Share | 44.38 |
| Working Capital | 460.52M |
Cash Flow
In the last 12 months, operating cash flow was $743.69 million and capital expenditures -$230.16 million, giving a free cash flow of $513.53 million.
| Operating Cash Flow | 743.69M |
| Capital Expenditures | -230.16M |
| Depreciation & Amortization | 653.90M |
| Net Borrowing | -340.56M |
| Free Cash Flow | 513.53M |
| FCF Per Share | $8.42 |
Margins
Gross margin is 34.47%, with operating and profit margins of 6.21% and -13.15%.
| Gross Margin | 34.47% |
| Operating Margin | 6.21% |
| Pretax Margin | -12.37% |
| Profit Margin | -13.15% |
| EBITDA Margin | 12.75% |
| EBIT Margin | 6.21% |
| FCF Margin | 5.14% |
Dividends & Yields
This stock pays an annual dividend of $1.44, which amounts to a dividend yield of 4.46%.
| Dividend Per Share | $1.44 |
| Dividend Yield | 4.46% |
| Dividend Growth (YoY) | 8.19% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 3.83% |
| Shareholder Yield | 8.29% |
| Earnings Yield | -66.86% |
| FCF Yield | 26.07% |
Analyst Forecast
The average price target for Concentrix is $35.25, which is 9.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $35.25 |
| Price Target Difference | 9.20% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 3.26% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Concentrix has an Altman Z-Score of 1.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 5 |